Immediate Impact
1 by Nobel laureates 3 from Science/Nature 78 standout
Citing Papers
Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
2022 Standout
Works of Thomas A. Golper being referenced
Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
2011
Continuous quality improvement: DOQI becomes K/DOQI and is updated
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas A. Golper | 3393 | 1233 | 1003 | 143 | 5.6k | |
| Kai Ming Chow | 2710 | 827 | 1043 | 182 | 5.1k | |
| Salim Mujais | 3697 | 1389 | 1383 | 120 | 5.7k | |
| George R. Bailie | 1992 | 873 | 500 | 139 | 4.2k | |
| Isaac Teitelbaum | 2498 | 823 | 813 | 102 | 4.0k | |
| Judith Bernardini | 3602 | 2027 | 860 | 94 | 4.8k | |
| Ram Gokal | 4209 | 1733 | 1510 | 189 | 5.6k | |
| Joanne M. Bargman | 5296 | 1972 | 1495 | 262 | 6.9k | |
| Yong-Lim Kim | 3187 | 846 | 1203 | 244 | 5.2k | |
| Alan S. Kliger | 3304 | 1296 | 721 | 152 | 5.0k | |
| Dimitrios G. Oreopoulos | 5923 | 1827 | 2158 | 386 | 8.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...